enVVeno Medical reported net income of -$3.60M for the quarter ended Jun 2026. This income statement covers 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.27M | 0.27M | 0.27M | 0.27M | 0.27M | 0.27M | 0.27M | 0.27M | 0.27M | 0.38M | 0.38M | 0.38M | 0.50M | 0.50M | 0.50M | 0.55M | 0.58M | 0.66M | 0.66M | 0.67M | |||||||||||||||||
| Revenue & cost | |||||||||||||||||||||||||||||||||||||
| Revenue | |||||||||||||||||||||||||||||||||||||
| Gross Profit | |||||||||||||||||||||||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 1.23M | 1.78M | 1.55M | 3.07M | 2.49M | 2.80M | 3.60M | 4.21M | 2.80M | 2.98M | 3.05M | 2.83M | 2.86M | 3.51M | 2.56M | 2.89M | 2.58M | 1.95M | 2.11M | 2.08M | |||||||||||||||||
| Selling, General & AdministrativeSG&A | 1.48M | 7.21M | 3.78M | 3.91M | 3.66M | 3.66M | 3.20M | 2.60M | 2.55M | 3.30M | 2.45M | 2.63M | 3.31M | 3.19M | 2.40M | 4.16M | 2.30M | 2.06M | 1.95M | 1.72M | |||||||||||||||||
| Other Operating ExpensesOther Opex | -0.00M | ||||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 2.71M | 8.99M | 5.33M | 6.99M | 6.15M | 6.46M | 6.80M | 6.81M | 5.35M | 6.28M | 5.50M | 5.45M | 6.17M | 6.70M | 4.95M | 7.05M | 4.88M | 4.01M | 4.06M | 3.80M | |||||||||||||||||
| Operating IncomeOp. Inc | -2.71M | -8.99M | -5.33M | -6.99M | -6.15M | -6.46M | -6.80M | -6.81M | -5.35M | -6.28M | -5.50M | -5.45M | -6.17M | -6.70M | -4.95M | -7.05M | -4.88M | -4.01M | -4.06M | -3.80M | |||||||||||||||||
| EBIT | -2.71M | -8.99M | -5.33M | -6.99M | -6.15M | -6.46M | -6.80M | -6.81M | -5.35M | -6.28M | -5.50M | -5.45M | -6.17M | -6.70M | -4.95M | -7.05M | -4.88M | -4.01M | -4.06M | -3.80M | |||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | |||||||||||||||||||||||||||||||||||||
| Non Operating Investment Income | -0.11M | -0.02M | 0.19M | 0.08M | 0.17M | 0.15M | 0.68M | 0.41M | 0.38M | 0.43M | 0.42M | 0.43M | 0.24M | 0.21M | 0.25M | 0.24M | 0.21M | ||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.01M | 0.01M | 0.04M | 0.07M | 0.04M | 0.04M | 0.04M | 0.04M | 0.05M | 0.06M | 0.07M | 0.09M | 0.16M | 0.22M | 0.20M | 0.17M | 0.10M | 0.02M | 0.01M | ||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.31M | ||||||||||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.32M | 0.01M | 0.01M | -0.08M | 0.05M | 0.28M | 0.41M | 0.34M | 0.35M | 0.63M | 0.51M | 0.50M | 0.53M | 0.47M | 0.45M | 0.35M | 0.34M | 0.28M | 0.21M | 0.20M | |||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||
| EBT | -2.70M | -8.99M | -5.33M | -6.95M | -6.08M | -6.42M | -6.75M | -6.78M | -5.30M | -6.23M | -5.44M | -5.38M | -6.08M | -6.54M | -4.74M | -6.85M | -4.71M | -3.91M | -4.04M | -3.79M | |||||||||||||||||
| Profit After TaxPAT | -2.39M | -8.99M | -5.33M | -7.06M | -6.10M | -6.18M | -6.39M | -6.47M | -5.00M | -5.65M | -4.99M | -4.96M | -5.64M | -6.23M | -4.50M | -6.69M | -4.54M | -3.74M | -3.85M | -3.60M | |||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -2.70M | -8.99M | -5.33M | -6.95M | -6.08M | -6.42M | -6.75M | -6.78M | -5.30M | -6.23M | -5.44M | -5.38M | -6.08M | -6.54M | -4.74M | -6.85M | -4.71M | -3.91M | -4.04M | -3.79M | |||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -2.70M | -8.99M | -5.33M | -6.95M | -6.08M | -6.42M | -6.75M | -6.78M | -5.30M | -6.23M | -5.44M | -5.38M | -6.08M | -6.54M | -4.74M | -6.85M | -4.71M | -3.91M | -4.04M | -3.79M | |||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -2.70M | -8.99M | -5.33M | -6.95M | -6.08M | -6.42M | -6.75M | -6.78M | -5.30M | -6.23M | -5.44M | -5.38M | -6.08M | -6.54M | -4.74M | -6.85M | -4.71M | -3.91M | -4.04M | -3.79M | |||||||||||||||||
| Preferred Dividend PaymentsPref Dividends | |||||||||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -2.39M | -8.99M | -5.33M | -6.95M | -6.08M | -6.42M | -6.75M | -6.78M | -5.30M | -6.23M | -5.44M | -5.38M | -6.08M | -6.54M | -4.74M | -6.85M | -4.71M | -3.91M | -4.04M | -3.79M | |||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -9.11 | -36.24 | -16.61 | -21.66 | -18.94 | -20.00 | -21.04 | -21.11 | -16.53 | -17.72 | -11.87 | -11.72 | -13.24 | -13.35 | -8.14 | -11.79 | -8.18 | -6.64 | -6.18 | -5.64 | |||||||||||||||||
| EPS (Diluted) | -21.66 | -18.94 | -20.00 | -21.04 | -21.11 | -16.53 | -17.72 | -11.87 | -11.72 | -13.24 | -13.35 | -8.14 | -11.79 | -8.18 | -6.64 | -6.18 | -5.64 | ||||||||||||||||||||
| Shares Outstanding | 0.26M | 0.25M | 0.32M | 0.32M | 0.32M | 0.32M | 0.32M | 0.32M | 0.32M | 0.35M | 0.46M | 0.46M | 0.46M | 0.49M | 0.58M | 0.58M | 0.58M | 0.59M | 0.65M | 0.67M | |||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.32M | 0.32M | 0.32M | 0.32M | 0.32M | 0.32M | 0.35M | 0.46M | 0.46M | 0.46M | 0.49M | 0.58M | 0.58M | 0.58M | 0.59M | 0.65M | 0.67M | ||||||||||||||||||||
| EBITDA | -2.71M | -8.99M | -5.33M | -6.99M | -6.15M | -6.46M | -6.80M | -6.81M | -5.35M | -6.28M | -5.50M | -5.45M | -6.17M | -6.70M | -4.95M | -7.05M | -4.88M | -4.01M | -4.06M | -3.80M | |||||||||||||||||
| Interest ExpensesInt Expense |